Login or sign up
For business

Dr. David A. Lombardi, Ph.D.

4.3· 4 reviews
Average ratingGreat
4.3/ 5

Based on 4 reviews

550%
425%
325%
20%
10%
Ask AI

Questions about Dr. David A. Lombardi, Ph.D.

Based on 4 reviews, listing data and website checks · updated 5 days ago

What is Dr. David A. Lombardi, Ph.D.?

Dr. David A. Lombardi, Ph.D. is an independent biostatistics consultant based in Natick, MA, offering study design and analysis services for the pharmaceutical and biopharmaceutical industries. He provides consulting on Phase I through IV clinical trials and real-world evidence (RWE) studies across multiple therapeutic areas including infectious diseases, vaccines, HIV-1, rotavirus, COVID-19, C. difficile infection, and antibiotics. His expertise also covers regulatory reporting, scientific publications, and communicating statistical findings to non-technical audiences.

What specific capability makes the firm stand out to clients?

The firm has extensive experience helping to prepare scientific publications and explaining intricate statistical findings to non-technical audiences. This capability is a key part of their service offering for clients in the pharmaceutical and biopharmaceutical sectors.

What major achievements have been attributed to the firm's work?

The firm has contributed significantly to the development of several novel therapeutic indications over the course of its career. This includes planning, conducting, analyzing, and reporting of Phase I, II, and III clinical trials and RWE outcomes research studies.

What academic credentials does the firm hold?

The firm holds a Ph.D. and M.S. from the University of Massachusetts at Amherst in Biostatistics and Epidemiology. This academic background underpins its professional summary and service delivery in the field.

What is the official website of Dr. David A. Lombardi, Ph.D.?

The official website of Dr. David A. Lombardi, Ph.D. is davidalombardi.com.

How is Dr. David A. Lombardi, Ph.D. rated on Trustburn?

On Trustburn, Dr. David A. Lombardi, Ph.D. has a rating of 4.3 out of 5 based on 4 reviews.

AI-generated from reviews on this page. Verify anything important with the company directly.

Eleanor Rigby
Reviews 1

Reading through the professional summary, it is clear that the specialists have a vast array of experience. They seem to cover nearly every major therapeutic area, from infectious diseases and oncology to regenerative medicine and ophthalmology. This breadth suggests that they are well-equipped to handle a wide variety of clinical trial types, including randomized controlled trials and cluster random trials. The mention of advanced statistical methods like structural equation models and propensity score matching indicates a high level of technical proficiency. It is reassuring to see such a detailed breakdown of skills, particularly the expertise in longitudinal modeling and survival analysis. For someone looking for reliable biostatistical support, this level of detail in the portfolio provides a strong indication of their capability to deliver high-quality results across different phases of drug development and real-world evidence studies.

Benjamin Clancy
Reviews 1

I was really impressed by the depth of knowledge listed here. Covering everything from Phase I pharmacokinetics to Phase IV registries is no small feat. It seems like the specialists have tackled a huge variety of therapeutic areas, including vaccines and oncology. The technical toolkit looks robust too, with advanced SAS programming and various statistical models clearly outlined. It gives me confidence that they can handle complex data challenges. I am curious though, does this pricing structure apply uniformly across all these different phases, or are there specific rates for real-world evidence studies? It would be helpful to know if the cost varies based on the complexity of the study design or the specific therapeutic area involved. The breadth of experience is definitely a strong point.

Arthur Penhaligon
Reviews 1

Dr. David A. Lombardi presents a professional portfolio that highlights extensive experience in biostatistics and epidemiological study design. The available information indicates a strong background in pharmaceutical and biopharmaceutical industries, covering phases I through IV clinical trials and real-world evidence outcomes. His educational credentials from the University of Massachusetts at Amherst provide a solid foundation for the advanced statistical methods described, including SAS programming and complex modeling techniques. The scope appears broad, spanning infectious diseases, oncology, and rare diseases, which suggests versatility in handling diverse therapeutic areas. For someone considering this company for consulting needs, the emphasis on rigorous programming specifications and clarity in clinical trial reporting seems promising. The detailed listing of statistical expertise implies a capable team ready to support complex analytical requirements in scientific publications and regulatory reporting.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Dr. David A. Lombardi, Ph.D.

David A. Lombardi, Ph.D. is an independent biostatistics consultant based in Natick, MA, offering study design and analysis services for the pharmaceutical and biopharmaceutical industries. He holds a Ph.D. and M.S. from the University of Massachusetts at Amherst in Biostatistics and Epidemiology and provides consulting on Phase I through IV clinical trials and real-world evidence (RWE) studies. His experience spans multiple therapeutic areas, including infectious diseases, vaccines, HIV-1, rotavirus, COVID-19, C. difficile infection, and antibiotics. He also assists with regulatory reporting, scientific publications, and communicating statistical findings to non-technical audiences.